DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Voltaren (Diclofenac) - Adverse Event Reports - Disability - Drug Interaction

 



Index of reports > Cases resulting in disability (17) > Cases with Drug Interaction (4)

Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in disability where reactions include drug interaction.

Adverse event in 56 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-04-04

Patient: 56 year old male, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Alkaline Phosphatase Increased, Enterocolitis Haemorrhagic, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Colonoscopy, Drug Interaction, Liver Disorder, Glycosylated Haemoglobin Increased, Colonic Stenosis, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Pancreatitis, Melaena, White Blood Cell Count Increased

Adverse event resulted in: disablity

Suspect drug(s):
Rocephin
    Dosage: 2 g/day
    Indication: Pyrexia
    Start date: 2007-02-07
    End date: 2007-02-13

Voltaren
    Dosage: 100 mg/day
    Indication: Pyrexia
    Start date: 2007-02-06
    End date: 2007-02-13

Other drugs received by patient: Futhan



Adverse event in 56 year old male receiving Voltaren (Diclofenac)

Reported by a physician from Japan on 2007-03-28

Patient: 56 year old male, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Blood Alkaline Phosphatase Increased, Enterocolitis Haemorrhagic, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Colonoscopy, Drug Interaction, Glycosylated Haemoglobin Increased, Colonic Stenosis, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Pancreatitis, Melaena, White Blood Cell Count Increased

Adverse event resulted in: disablity

Suspect drug(s):
Rocephin
    Dosage: 2 g/day
    Indication: Pyrexia
    Start date: 2007-02-07
    End date: 2007-02-13

Voltaren
    Dosage: 100 mg/day
    Indication: Pyrexia
    Start date: 2007-02-06
    End date: 2007-02-13

Other drugs received by patient: Futhan



Adverse event in 80 year old female receiving Voltaren (Diclofenac)

Reported by a individual with unspecified qualification from Norway on 2007-01-30

Patient: 80 year old female

Adverse reactions / side effects: Paraplegia, Spinal Epidural Haemorrhage, Urinary Tract Infection, Drug Interaction, Conus Medullaris Syndrome

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Voltaren
    Administration route: Oral

Morphine
    Administration route: Oral

Neurontin
    Dosage: 400 mg, 5qd
    Administration route: Oral

Paracet
    Administration route: Oral

Levaxin
    Administration route: Oral

Simvastatin
    Dosage: 40 mg, qd
    Administration route: Oral

Tegretol
    Dosage: 100 mg, bid
    Administration route: Oral

Warfarin Sodium
    Dosage: 2.5 mg, 3 to 4 times/day
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2006-11-30



Adverse event in 80 year old female receiving Voltaren (Diclofenac)

Reported by a health professional (non-physician/pharmacist) from Norway on 2007-01-26

Patient: 80 year old female

Adverse reactions / side effects: Blood Pressure Increased, Paraplegia, Blood Potassium Decreased, Spinal Epidural Haemorrhage, International Normalised Ratio Increased, Drug Interaction

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Zocor
    Administration route: Oral

Voltaren
    Administration route: Oral

Levaxin
    Administration route: Oral

Marevan
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2006-11-30

Paracet
    Administration route: Oral

Tegretol
    Administration route: Oral

Other drugs received by patient: Morfin; Neurontin

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009